Linezolid som behandling af infektiøs endokarditis

Trine Kiilerich Lauridsen*, Magnus Arpi, Niels Eske Bruun

*Corresponding author af dette arbejde

    Publikation: Bidrag til tidsskriftArtikelForskningpeer review


    In Denmark enterococci causes 15 to 20% of all endocarditis (IE) cases. The development of multi-resistant bacterial strains has increased the need for new antibiotics. Linezolid is an alternative to conventional treatment of infections with gram positive cocci. In this case report linezolid was used to treat IE in a patient, who was allergic to penicillin and where conventional treatment caused development of acute renal failure. No side effects were observed and the patient responded well to the treatment.

    Bidragets oversatte titelLinezolid therapy for infectious encocarditis
    TidsskriftUgeskrift for laeger
    Udgave nummer16
    StatusUdgivet - 1 apr. 2010


    Udforsk hvilke forskningsemner 'Linezolid som behandling af infektiøs endokarditis' indeholder.